Browsing by Author "Abdelghani, Amani A"

Now showing 1 - 2 of 2

Aspirin-based organoiron dendrimers as promising anti-inflammatory, anticancer, and antimicrobial drugs
(MDPI, 10/22/2021) Abd-El-Aziz, Alaa S; Benaaisha, Maysun R; Abdelghani, Amani A; Bissessur, Rabin; Abdel-Rahman, Laila H; Fayez, Ahmed M; Abou El-ezz, Doaa
Designing nanocarriers with actions directed at a specific organ or tissue is a very promising strategy since it can significantly reduce the toxicity of a bioactive drug. In this study, an organometallic dendrimer was used to synthesize a biocompatible drug delivery system by attaching aspirin to the periphery of the dendrimer. Our goal is to enhance the bioavailability and anticancer activity of aspirin and reduce its toxicity through successive generations of organoiron dendrimers. The biological activity of aspirin-based dendrimer complexes was evaluated. The result of antimicrobial activity of the synthesized dendrimers also demonstrated an increase in their antimicrobial activity with increased generation of the dendrimers for most types of microorganisms. This study reveals for the first time that organoiron dendrimers linked with aspirin exhibit an excellent Gram-negative activity comparable to the reference drug Gentamicin. All synthesized dendrimers were tested for their anticancer activity against breast cancer cell lines (MCF-7), hepatocellular cell lines (Hep-G2), and a non-cancer cell line, Human Embryonic Kidney (HEK293), using the MTT cell viability assay and compared against a standard anticancer drug, Doxorubicin. Compounds G3-D9-Asp and G4-D12-Asp exhibited noticeable activity against both cell lines, both of which were more effective than aspirin itself. In addition, the in vivo anti-inflammatory activity and histopathology of swollen paws showed that the designed aspirin-based dendrimers displayed significant anti-inflammatory activity; however, G2-D6-Asp showed the best anti-inflammatory activity, which was more potent than the reference drug aspirin during the same period. Moreover, the coupling of aspirin to the periphery of organoiron dendrimers showed a significant reduction in the toxicity of aspirin on the stomach.
Novel Bromo and methoxy substituted Schif base complexes of Mn(II), Fe(III), and Cr(III) for anticancer, antimicrobial, docking, andADMET studies
(2023-02) Abdel‑Rahman, Laila H; Abdelghani, Amani A; AlObaid, Abeer A; El‑ezz, Doaa Abou; Warad, Ismail; Shehata, Mohamed R; Abdalla, Ehab M
In this study, four new Mn(II), Fe(III), and Cr(III) complexes with two Schif base ligands namely, 4-bromo-2-[(E)-{[4-(2-hydroxyethyl)phenyl]imino}methyl]phenol (HL1) and 2-[(E)-{[4-(2-hydroxyethyl) phenyl]imino}methyl]-4-methoxy phenol (HL2) have been synthesized and characterized. Diferent analytical and spectral methods have been used to characterize the ligands and their complexes. General formulas of [M(L)Cl2(H2O)2] for FeL1, CrL1 and CrL2, and [M(L)Cl(H2O)3] for MnL2 were proposed. HOMO and LUMO energies, as well as the electrical characteristics, have been calculated using DFT/B3LYP calculations with Gaussian 09 program. The optimized lowest energy confgurations of the complexes are proven. The disc difusion technique was used to test the pharmacological activities’ antibacterial efcacy against diverse bacterial and fungus species. The MTT technique was used to assess the in vitro cytotoxicity of the ligands and their metal complexes on the Hep-G2 human liver carcinoma cell line and the MCF-7 human breast cancer cell line. All compounds displayed better activity compared to the free ligands. MnL2 complex showed predominant activity when compared to the other complexes with an IC50 value of 2.6 ± 0.11 μg/ml against Hep-G2, and against MCF-7 the IC50 value was 3.0 ± 0.2 μg/ml which is less than the standard drug cisplatin (4.0 μg/ml). UV–vis electronic spectrum and gel electrophoresis techniques have been used to investigate the compounds’ afnity to bind and cleavage CT-DNA. The interaction’s binding constants, or Kb, have been identifed, and it was discovered that the new complexes’ binding afnities are in the order of FeL1>MnL2 >CrL2 >CrL1, and the binding mechanism has been suggested. To assess the kind of binding and binding afnity of the investigated drugs with human DNA, a molecular docking study was carried out (PDB:1bna). The acquired results supported the intercalation binding mechanism proposed in the experimental part and revealed that complexes may be inserted into the DNA molecule to stop DNA replication. According to ADMET data, the synthesized compounds have a high bioavailability profle and their physicochemical and pharmacological features remained within Lipinski’s RO5 predicted limitations.